43 related articles for article (PubMed ID: 15604094)
1. Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target.
Lee TK; Man K; Ho JW; Wang XH; Poon RT; Sun CK; Ng KT; Ng IO; Xu R; Fan ST
Carcinogenesis; 2005 Mar; 26(3):681-7. PubMed ID: 15604094
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Effects of FTY720 and its Derivatives.
Han M; Liu X; Hailati S; Maihemuti N; Nurahmat N; Dilimulati D; Baishan A; Aikebaier A; Zhou W; Pan Y
Curr Top Med Chem; 2024; 24(3):192-200. PubMed ID: 38185890
[TBL] [Abstract][Full Text] [Related]
3. Rac1/PAK1 signaling contributes to bone cancer pain by Regulation dendritic spine remodeling in rats.
Xu L; Yang L; Wu Y; Wan X; Tang X; Xu Y; Chen Q; Liu Y; Liu S
Mol Pain; 2023; 19():17448069231161031. PubMed ID: 36938611
[TBL] [Abstract][Full Text] [Related]
4. Transmembrane serine protease 2 cleaves nidogen 1 and inhibits extrahepatic liver cancer cell migration and invasion.
Ma YB; Qiao JW; Hu X
Exp Biol Med (Maywood); 2023 Jan; 248(2):91-105. PubMed ID: 36408877
[TBL] [Abstract][Full Text] [Related]
5. RHO GTPase family in hepatocellular carcinoma.
Wang T; Rao D; Yu C; Sheng J; Luo Y; Xia L; Huang W
Exp Hematol Oncol; 2022 Nov; 11(1):91. PubMed ID: 36348464
[TBL] [Abstract][Full Text] [Related]
6. SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway.
Matsushima-Nishiwaki R; Yamada N; Hattori Y; Hosokawa Y; Tachi J; Hori T; Kozawa O
PLoS One; 2022; 17(1):e0262485. PubMed ID: 35007301
[TBL] [Abstract][Full Text] [Related]
7. Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma.
Dimri M; Satyanarayana A
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32093152
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA SchLAH suppresses metastasis of hepatocellular carcinoma through interacting with fused in sarcoma.
Ge Z; Cheng Z; Yang X; Huo X; Wang N; Wang H; Wang C; Gu D; Zhao F; Yao M; Fan J; Qin W
Cancer Sci; 2017 Apr; 108(4):653-662. PubMed ID: 28196303
[TBL] [Abstract][Full Text] [Related]
9. TIPE2 suppresses angiogenesis and non-small cell lung cancer (NSCLC) invasiveness via inhibiting Rac1 activation and VEGF expression.
Li Z; Guo C; Liu X; Zhou C; Zhu F; Wang X; Wang Q; Shi Y; Wang J; Zhao W; Zhang L
Oncotarget; 2016 Sep; 7(38):62224-62239. PubMed ID: 27556698
[TBL] [Abstract][Full Text] [Related]
10. Integrin β6 serves as an immunohistochemical marker for lymph node metastasis and promotes cell invasiveness in cholangiocarcinoma.
Li Z; Biswas S; Liang B; Zou X; Shan L; Li Y; Fang R; Niu J
Sci Rep; 2016 Jul; 6():30081. PubMed ID: 27440504
[TBL] [Abstract][Full Text] [Related]
11. The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod.
Patmanathan SN; Yap LF; Murray PG; Paterson IC
J Cell Mol Med; 2015 Oct; 19(10):2329-40. PubMed ID: 26171944
[TBL] [Abstract][Full Text] [Related]
12. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
[TBL] [Abstract][Full Text] [Related]
13. A bibenzyl from Dendrobium ellipsophyllum inhibits migration in lung cancer cells.
Chaotham C; Chanvorachote P
J Nat Med; 2015 Oct; 69(4):565-74. PubMed ID: 26109451
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of microRNA-100 enhances the ICMT-Rac1 signaling and promotes metastasis of hepatocellular carcinoma cells.
Zhou HC; Fang JH; Luo X; Zhang L; Yang J; Zhang C; Zhuang SM
Oncotarget; 2014 Dec; 5(23):12177-88. PubMed ID: 25361001
[TBL] [Abstract][Full Text] [Related]
15. Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1.
Cao X; Zhang L; Shi Y; Sun Y; Dai S; Guo C; Zhu F; Wang Q; Wang J; Wang X; Chen YH; Zhang L
Mol Cancer; 2013 Nov; 12(1):149. PubMed ID: 24274578
[TBL] [Abstract][Full Text] [Related]
16. MiR-23a-mediated inhibition of topoisomerase 1 expression potentiates cell response to etoposide in human hepatocellular carcinoma.
Wang N; Zhu M; Tsao SW; Man K; Zhang Z; Feng Y
Mol Cancer; 2013 Oct; 12(1):119. PubMed ID: 24103454
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of engulfment and cell motility 1 promotes cell invasion and migration of hepatocellular carcinoma.
Jiang J; Liu G; Miao X; Hua S; Zhong D
Exp Ther Med; 2011 May; 2(3):505-511. PubMed ID: 22977532
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis.
Sanada Y; Mizushima T; Kai Y; Nishimura J; Hagiya H; Kurata H; Mizuno H; Uejima E; Ito T
PLoS One; 2011; 6(9):e23933. PubMed ID: 21931623
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of JNK1 expression decreases migration and invasion of mouse hepatocellular carcinoma cell line in vitro.
Zhang YH; Wang SQ; Sun CR; Wang M; Wang B; Tang JW
Med Oncol; 2011 Dec; 28(4):966-72. PubMed ID: 20490718
[TBL] [Abstract][Full Text] [Related]
20. Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity.
Jajoo S; Mukherjea D; Watabe K; Ramkumar V
Neoplasia; 2009 Nov; 11(11):1132-45. PubMed ID: 19881949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
